| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/17/2010 | EP1491206B1 Use of peptide derivatives for inducing cell differentiation |
| 11/17/2010 | EP1420821B1 Immunologically significant herpes simplex virus antigens and methods for using same |
| 11/17/2010 | EP1204682B1 Compositions and methods for the treatment of tumors |
| 11/17/2010 | EP1181358B1 Methods and materials for generating sh3 domains with tailored binding properties |
| 11/17/2010 | CN201631201U Disposable flexibly connected parallel multi-tube anti-coagulation hemostix |
| 11/17/2010 | CN101889084A Protease variants for pharmaceutical use |
| 11/17/2010 | CN101889083A Recombinant preparation of selected bromelain fractions |
| 11/17/2010 | CN101889024A FVIII peptides and their use in tolerising haemophiliacs |
| 11/17/2010 | CN101889023A Purification of PEGylated polypeptides |
| 11/17/2010 | CN101889007A Method for amplifying hematopoietic stem cells using heterocyclic compound |
| 11/17/2010 | CN101888851A Methods for treatment of stroke or cerebrovascular accidents using an etb receptor agonist |
| 11/17/2010 | CN101888850A Peptide compounds for treating obesity and insulin resistance |
| 11/17/2010 | CN101888849A Sclerostin and the inhibition of wnt signaling and bone formation |
| 11/17/2010 | CN101888793A Nutritional formulation with high energy content |
| 11/17/2010 | CN101886123A Application of vascular endothelial growth factor receptor-2 (VEGFR-2) in temporomandibular joint disturbance |
| 11/17/2010 | CN101886066A Treatment effect of tissue plasminogen activator kringle-2 on stroke and preparation method for tissue plasminogen activator kringle-2 |
| 11/17/2010 | CN101884811A Bone grafting material of gradient porous beta-TCP with bioactivity and anti-infection effect, preparation method and application thereof |
| 11/17/2010 | CN101884789A Ctgf as target for the therapy of diabetic nephropathy |
| 11/17/2010 | CN101884786A Medicament for preventing and treating dental caries |
| 11/17/2010 | CN101884785A Enzymolysis ovalbumin compound oral liquid |
| 11/17/2010 | CN101884784A Bv8 nucleic acids and polypeptides with mitogenic activity |
| 11/17/2010 | CN101884783A Wheat bran polypeptide-containing anti-fatigue traditional Chinese medicine and preparation method thereof |
| 11/17/2010 | CN101884782A Application of bifidobacterium longum adherence inhibition protein Aip for preventing and treating diarrhea |
| 11/17/2010 | CN101884781A Pharmaceutical composition for preventing or treating rejection reaction of organ or tissue transplantation or graft versus host reaction of bone marrow transplantation |
| 11/17/2010 | CN101884780A Use of hepcidin as a regulator of iron homeostasis |
| 11/17/2010 | CN101884630A Taltirelin solid preparation |
| 11/17/2010 | CN101357224B Kidney-tonifying and health-preserving preparation |
| 11/17/2010 | CN101327317B Injection for treating cancer and its preparation method |
| 11/17/2010 | CN101311192B Process for high-efficiency expressing sTNFR/Fc fusion protein in yeast and uses thereof |
| 11/17/2010 | CN101255410B Method for constructing hepatitis C virus specific ribozyme M1GS-hcv/C76 and uses thereof |
| 11/17/2010 | CN101073666B Method for producing kallidin proenzyme raw-material medicine |
| 11/17/2010 | CN101068565B Compositions containing lipase, protease and amylase for treating pancreatic insufficiency |
| 11/16/2010 | US7834258 Dimer of chimeric recombinant binding domain-functional group fusion formed via disulfide-bond-bridge and the processes for producing the same |
| 11/16/2010 | US7834159 Pharmacokinetics; glycosyltransferases; vaccines |
| 11/16/2010 | US7834156 Monoclonal antibody comprising cytotoxic fusion for use in treatment of cell proliferative disorers |
| 11/16/2010 | US7834152 Antagonists of interleukin-15 |
| 11/16/2010 | US7834151 Fibrinogen binding protein for use in diagnosis, prevention and treatment of Staphylococcal infection; bactericides; wound healing agents |
| 11/16/2010 | US7834150 Isolated cold-and-menthol-sensitive receptor (CMR1) |
| 11/16/2010 | US7834149 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis nervous system disorders and infections |
| 11/16/2010 | US7834147 Saposin C-DOPS: a novel anti-tumor agent |
| 11/16/2010 | US7834145 HCV protease substrates |
| 11/16/2010 | US7834143 Cell surface receptor for use as tool in identifying modulators of vascular pressure |
| 11/16/2010 | US7834141 Antiproliferative agents; gonadotropin releasing factor; binding to tumor and cancer cells; Chicken II GnRH analog; resistant to degradation by post-proline peptidases |
| 11/16/2010 | US7834140 Polypeptide fragment of constitutive coactivator of PPARgamma |
| 11/16/2010 | US7834139 Magnetic nanotubes |
| 11/16/2010 | US7834057 applying first composition containing glycolic acid, second containing Ascorbylmethylsilanol Pectinate, and third including Retinyl Palmitate Polypeptide, Ascorbylmethylsilanol Pectinate, Tocopheryl Polypeptide, Cholecalciferol Polypeptide, and Niacinamide Polypeptide |
| 11/16/2010 | US7834055 Compositions and methods for the treatment of skin |
| 11/16/2010 | US7833992 biological conjugates used for drug delivery; side effect reduction |
| 11/16/2010 | US7833986 Dipeptides and tripeptides for treating inflammatory reactions, including allergic reactions associated with asthma, rhinitis, conjunctivitis, atopic dermatitis and intestinal anaphylaxis; cyclohexylalanine-L-glutamic acid-glycine |
| 11/16/2010 | US7833985 tripeptides as hypotensive agent for reducing blood pressure; edible; being of food origin; from sesame meal |
| 11/16/2010 | US7833984 modulator of PKC V5 isozyme-specific peptide, or a modification, derivation, fragment, combination, or hybrid thereof; treatment of pain, cancer |
| 11/16/2010 | US7833983 polypeptide comprising a symmetrical dimethylated arginine, is used for diagnosing systemic lupus erythematosus |
| 11/16/2010 | US7833982 Methods of treating dermal ulcers with thrombin derived peptides |
| 11/16/2010 | US7833981 glycoprotein having the removal of sialic acid from the end of the glycoside chain; for treatment of infectious and inflammatory diseases, female fertility disorders, autoimmune disorders, tumors, fungal infections |
| 11/16/2010 | US7833980 Compositions and methods for inhibiting cell migration |
| 11/16/2010 | US7833979 conjugated polymer drug contains toxin protein and polyethylene glycol; treating autoimmune diseases, such as multiple sclerosis, type 1 diabetes, psoriasis, inflammatory bowel disease, dermatitis, rheumatoid arthritis, psoriasis; asthma, allergy, restinosis, fibrosis, scleroderma, glomerulonephritis |
| 11/16/2010 | US7833978 polymer conjugated drug contains a recombinant epidermal growth factor (EGF)-like domains and polyethylene glycol; also conjugated with glycolipid, glycoprotein and polysaccharide; as anticoagulants for injured blood vessels |
| 11/16/2010 | US7833977 Use of L-carnitine for the treatment of cataract of non diabetic origin due to altered chaperone proteins by stabilizing the protein activity |
| 11/16/2010 | US7833976 administering an antitumor agent containing a combination of an alpha v beta 3 angiogenisis antagonist and an anti-tumor immunotherapeutic agent, which is a fusion protein of a cytokine IL-2 and an Ig heavy chain that immunoreacts with a tumor associated antigen target; drug target |
| 11/16/2010 | US7833974 Polypeptide biodrugs with given amino acid sequence which includes phosphorylated serine or threonine conjugated to a hydrophobic moiety such as a fatty acid; treating disorders such as Type II Diabetes, neurodegenerative diseases and psychological disorders |
| 11/16/2010 | US7833973 comprising ziconotide, methionine and hydromorphone for producing analgesia in a mammalian subject; reduces the side effects, no drug interactions |
| 11/16/2010 | US7833972 Proteins and use thereof |
| 11/16/2010 | US7833970 Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules |
| 11/16/2010 | US7833969 T-helper cell peptide epitopes for use in targeting and treatment of cell prolferative disorders; immunotherapy |
| 11/16/2010 | US7833967 polypeptide having antimicrobial activity, having an amino acid sequence selected from e.g. Arg Arg Arg Pro Pro Arg Leu Pro Arg Pro Phe Pro; Phe Arg Pro Pro Pro Arg Pro Arg Pro Leu Pro Val; detergents, animal feed |
| 11/16/2010 | US7833966 topically administering cyclosporine to an eye of an individual having loss of corneal sensation after refractive surgery on the eye under conditions of at least daily dosing intervals in a therapeutic regimen for a duration sufficient to provide an enhanced rate of restoration of corneal sensitivity |
| 11/16/2010 | US7833965 Biocompatible liquid, biocompatible gas, and solid particles of a biocompatible polymer are mixed together to form a homogenous composition including a discontinuous gas phase with solid particles homogenously dispersed throughout a continuous liquid phase |
| 11/16/2010 | US7833964 Administering to the subject a therapeutically effective amount of a compound that increases the bioactive serum levels of insulin-like growth factor-1 in the subject, thereby ameliorating negative effects of visceral obesity; treatment of cardiovascular disease and the metabolic syndrome |
| 11/16/2010 | US7833963 For use as an anticancer agent and an immunosuppressive agent |
| 11/16/2010 | US7833791 Lactobacilli expressing biologically active polypeptides and uses thereof |
| 11/16/2010 | US7833790 Wound dressings comprising oxidized cellulose and human recombinant collagen |
| 11/16/2010 | US7833783 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
| 11/16/2010 | US7833765 Galenic formulation for colon-targeted delivery of active ingredients |
| 11/16/2010 | US7833753 Mixture comprising sialinated erythropoietin (EPO) for use in generating stable, human, recombinant proteins that are modified post-translationally |
| 11/16/2010 | US7833750 Card-domain containing polypeptides, encoding nucleic acids, and methods of use |
| 11/16/2010 | US7833742 Fabry disease; X-linked inherited lysosomal storage disease characterized by severe renal impairment, angiokeratomas, and/or cardiovascular abnormalities; selecting a human alpha -Gal A preparation having a desired pharmacokinetic parameter |
| 11/16/2010 | US7833722 Ligands for G protein-coupled receptor protein and use thereof |
| 11/16/2010 | US7833717 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development |
| 11/16/2010 | US7833712 Diagnosis of lung cancer in mammals; obtain sample, extract nucleotide sequences, screen for methylated nucleotide sequences, compare methylation profile with healthy cells, evaluate for cancer; tumor suppressor lung cancer 1 (TSLC1) |
| 11/16/2010 | US7833545 Methods and devices for the sustained release of multiple drugs |
| 11/16/2010 | US7833535 Neuropeptide Y, kyotorphin, calcitonin-gene related peptides bind receptors; Clostridial toxin HN domain translocates toxin light chain across endosome membrane;Clostridial toxin light chain cleaves a neurosecretory protein; HC domain modified to reduce binding to receptors at neuromuscular junction |
| 11/16/2010 | US7833531 means of delivering the GLP-1 peptide in a sustained manner; obesity related disorders |
| 11/16/2010 | US7833526 Using antisense agents and or immunoglobulins as modulators of cell death; treating cell proliferative and reproductive disorders |
| 11/16/2010 | US7833523 DispersinB polypeptide for use in preventing, inhibiting and treating bacterial infections |
| 11/16/2010 | US7833522 forming a nascent skin graft on a wound area by applying a plurality of individual epidermal cells to that wound area |
| 11/16/2010 | US7833521 Admnistering a fusion protein of interferon and albumin or an albumin variant, having a higher plasma stability than unfused interferon; albumin or variant is located either at the N-terminus or C-terminus of the fusion protein, fusion protein retains the therapeutic activity of unfused interferon |
| 11/16/2010 | US7833520 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
| 11/16/2010 | US7833270 physical structure which allows for implantation and retention into host bone and dense polymer scaffold making up construct of physical structure, the dense polymer scaffold impregnated with calcium phosphate particles comprising hydroxyapatite and tricalcium phosphate and collagen and growth factor |
| 11/16/2010 | CA2523216C Recombinant alphavirus vectors |
| 11/16/2010 | CA2455223C Crfr1 selective ligands |
| 11/16/2010 | CA2422622C Novel baff-r nucleic acids and polypeptides |
| 11/16/2010 | CA2405704C Bombesin analogs for treatment of cancer |
| 11/16/2010 | CA2402278C Diabetic nutritionals |
| 11/16/2010 | CA2400872C Cyclic hexapeptide derivatives |
| 11/16/2010 | CA2398901C Methods and compositions for treating conditions of the eye |
| 11/16/2010 | CA2315878C Kappa receptor opioid peptides |
| 11/16/2010 | CA2311648C Ifnar2/ifn complex |
| 11/16/2010 | CA2278151C Heregulin variants |
| 11/16/2010 | CA2240339C [3'-desoxy-3'-oxo-mebmt]1-[val]2-ciclosporin-containing emulsion pharmaceutical composition |
| 11/16/2010 | CA2237159C Glycosaminoglycan-antithrombin iii/heparin cofactor ii conjugates |